Key Updates
British American Tobacco has advanced +2.04% since the last report to £4,662, extending YTD gains to +10.63% and building on the previous recovery momentum. The stock continues its positive trajectory following the strong FY2025 results released on February 12, with recent price action consolidating gains near multi-month highs. New developments include the closure of BAT's South African manufacturing facility due to illicit trade concerns, ongoing U.S. litigation related to North Korea sanctions violations, and competitive dynamics in the nicotine pouch market where Velo gains share against Philip Morris's Zyn.
Current Trend
BAT shares demonstrate sustained upward momentum with +10.63% YTD performance, significantly outperforming the +1.64% level from mid-February. The stock has posted consecutive positive periods: +0.71% (1d), +2.04% (5d), +7.62% (1m), and +12.45% (6m), establishing a clear uptrend. The £4,662 level represents near-term resistance following the +6.68% surge post-earnings, while the £4,283-£4,381 range from mid-February now serves as support. The stock has recovered all losses from the early February pullback and trades at elevated levels relative to the £4,215 year-start baseline.
Investment Thesis
The investment case centers on BAT's successful transformation toward reduced-risk products while maintaining robust cash generation from traditional tobacco. The company delivered exceptional FY2025 results with pretax profit surging to £9.86 billion from £3.54 billion, adjusted operating profit rising to £11.89 billion (exceeding consensus £11.29 billion), and new categories revenue growing 7% to £3.62 billion. The 2% dividend increase to 245.04 pence per share reinforces the income appeal. However, the thesis faces headwinds from illicit trade (75% of South Africa's market, 70% of U.S. vapes), regulatory risks including the North Korea sanctions lawsuit seeking unspecified damages, and intensifying competition in next-generation products despite Velo's U.S. market share gains.
Thesis Status
The thesis strengthens materially with FY2025 results validating the transformation strategy and profit growth trajectory. The £11.89 billion adjusted operating profit and £3.62 billion new categories revenue demonstrate successful execution despite a 1% total revenue decline to £25.61 billion (largely FX-driven). However, new risks emerge: the South African factory closure signals deteriorating market conditions in key geographies, the North Korea-related lawsuit introduces significant legal overhang (following the $629 million settlement), and competitive pressures from Philip Morris intensify despite Velo's gains. The potential U.S. ITC import block on unauthorized vapes could materially improve market dynamics but won't impact results until 2027. Overall, fundamental performance validates the thesis while operational and legal challenges warrant monitoring.
Key Drivers
BAT's exceptional FY2025 results drive current momentum, with pretax profit reaching £9.86 billion versus £3.54 billion prior year and adjusted operating profit of £11.89 billion beating consensus. The 2.3% profit increase to £11.28 billion reflects Velo's U.S. market share gains through higher nicotine strengths and promotional strategies. However, BAT announced closure of its South African factory as illicit cigarettes comprise 75% of the market, costing billions in lost tax revenue. The potential U.S. ITC import block on unauthorized vapes could reduce illegal e-cigarette sales by one-third, though impact unlikely before 2027. Legal risks persist as nearly 200 American terrorism victims filed lawsuit over North Korea operations following the $629 million penalty settlement.
Technical Analysis
BAT exhibits strong technical momentum trading at £4,662, up +10.63% YTD and +12.45% over six months. The stock broke through the £4,569 resistance established on February 20 and now tests the £4,662 level following the post-earnings rally. Support has established at £4,381 (February 13 level) with secondary support at £4,283 (February 16 low). The consecutive positive periods across all timeframes (1d: +0.71%, 5d: +2.04%, 1m: +7.62%) indicate sustained buying pressure. The stock has recovered the entire -2.24% and -2.30% declines from mid-February, suggesting strong demand absorption. Volume patterns around the February 12 earnings release likely established new accumulation levels. The £4,662 level represents a critical test of near-term resistance, with a break above potentially targeting the £4,800-£5,000 range based on the current trajectory.
Bull Case
- Exceptional profit growth with pretax profit surging to £9.86 billion from £3.54 billion YoY, demonstrating successful business transformation and operational leverage. Source: Wall Street Journal
- New categories revenue grew 7% to £3.62 billion with Velo gaining U.S. market share against competitors through higher nicotine strengths and promotional strategies. Source: Reuters
- Potential U.S. ITC import block could reduce illegal e-cigarette market by one-third, with full determination expected in March and presidential review following, addressing the 70% unregulated device problem. Source: Reuters
- Dividend increased 2% to 245.04 pence per share, maintaining attractive income profile while adjusted operating profit of £11.89 billion exceeded consensus £11.29 billion. Source: Morningstar
- Strong price momentum with +10.63% YTD and +12.45% six-month performance, establishing technical support at £4,381 and demonstrating sustained investor demand post-earnings. Source: Price data provided
Bear Case
- Nearly 200 American terrorism victims filed lawsuit seeking unspecified damages over North Korea operations that allegedly generated $418 million funding weapons programs, following $629 million penalty settlement. Source: PR Newswire
- Closure of South African factory after 50+ years of operation due to illicit cigarettes comprising 75% of market, signaling deteriorating conditions in key emerging markets and loss of manufacturing capacity. Source: Bloomberg
- Philip Morris reported smoke-free revenues reaching $17 billion with products serving 43 million consumers across 106 markets, intensifying competitive pressure despite BAT's Velo gains. Source: Business Wire
- Total revenue declined 1% to £25.61 billion with 3.1% FX headwind, while vape volumes fell nearly 13% in 2025 due to illegal product sales in U.S. and Canada comprising 70% of market. Source: Bloomberg
- Any ITC import block impact on unauthorized vapes unlikely before 2027 due to long supply chains and large existing inventories, delaying potential market share recovery in key growth category. Source: Reuters